Here, of the four major MAPK pathway modules, the JNK pathway (42.1% of the tumours) and the p38 pathway (40.3%) showed the highest frequencies of MAPK pathway gene mutations, followed by the ERK1/2 pathway (33.7%) and the ERK5 pathway (6.1%); (Fig. 1). This evidence concerns the gene CRK and neoplasm.